Page 5 - Heart Transplant Protocol
P. 5
Heart Function Service: Heart Transplant Protocols
Surveillance ............................................................................................................................................. 27
Contributing Factors and Interventions .................................................................................................. 27
Classification and Severity of CAV by Angiogram ................................................................................... 27
Management ........................................................................................................................................... 28
Anticoagulation Following Stents ........................................................................................................... 28
Hypertension Protocol ................................................................................................................................ 29
Immediate Post-Transplant Management .............................................................................................. 29
Standard education regarding blood pressure control ........................................................................... 29
Post-Transplant Infection ............................................................................................................................ 30
Prophylaxis .............................................................................................................................................. 30
Mycostatin (Nystatin) ......................................................................................................................... 30
Trimethoprim/sulfamethoxazole (Bactrim) ........................................................................................ 30
Valganciclovir (Valcyte) ....................................................................................................................... 30
Protocols for the management of EBV infection and EBV associated PTLD ........................................... 30
Definitions ........................................................................................................................................... 31
Major Risk Factors: .............................................................................................................................. 31
EBV PCR: .............................................................................................................................................. 31
Pretransplant screening: ..................................................................................................................... 31
EBV Viral Load Monitoring and Preemptive Therapy ......................................................................... 31
Evaluation and management of patients with an elevated EBV PCR will proceed as follows:........... 32
Treatment of EBV Disease / PTLD ....................................................................................................... 32
Protocols for CMV Prophylaxis and Management of CMV Infection ..................................................... 33
Pneumocystis carinii pneumonia (PCP) Prophylaxis Protocol ................................................................ 35
Immunization Protocol ............................................................................................................................... 37
Heart Transplant Checklist for New Referral .............................................................................................. 38
Evaluation/Listing Checklist ........................................................................................................................ 39
Referring Physician Notification Protocol ................................................................................................... 41
Referring Physician Listing Notification Letter ............................................................................................ 42
Outpatient Follow-up .................................................................................................................................. 43
Pre-transplant Outpatient Follow-up Protocols ..................................................................................... 43
Listed Status 1A: VAD Patient ............................................................................................................. 43
Listed Status 1B ................................................................................................................................... 43
Updated November 9, 2017 5
